Growth patterns in children with mucopolysaccharidosis I and II.

about

Birth weight in patients with mucopolysaccharidosis type II: Data from the Hunter Outcome Survey (HOS).Short stature as a presenting symptom of attenuated Mucopolysaccharidosis type I: case report and clinical insights

P2860

Q33660434-1A230B2D-A234-4FE4-BAAF-A799FD786C58 Q59136190-1F01CFDF-44A2-4A02-9AFD-F2AEDB9D818F

P2860

Growth patterns in children with mucopolysaccharidosis I and II.

Item

http://www.wikidata.org/entity/Q47587025

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

Growth patterns in children with mucopolysaccharidosis I and II.

@en

Growth patterns in children with mucopolysaccharidosis I and II.

@nl

type

Item

label

Growth patterns in children with mucopolysaccharidosis I and II.

@en

Growth patterns in children with mucopolysaccharidosis I and II.

@nl

prefLabel

Growth patterns in children with mucopolysaccharidosis I and II.

@en

Growth patterns in children with mucopolysaccharidosis I and II.

@nl

P1476

Growth patterns in children with mucopolysaccharidosis I and II

@en

P2093

Agnieszka Jurecka

http://www.w3.org/2001/XMLSchema#string

Joachim Cieślik

http://www.w3.org/2001/XMLSchema#string

P2860

Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy

A clinical study of 77 patients with mucopolysaccharidosis type II

Heparan sulphate proteoglycans fine-tune mammalian physiology

Impaired elastogenesis in Hurler disease: dermatan sulfate accumulation linked to deficiency in elastin-binding protein and elastic fiber assembly.

Mucopolysaccharidosis type IIIB may predominantly present with an attenuated clinical phenotype

The effect of idursulfase on growth in patients with Hunter syndrome: data from the Hunter Outcome Survey (HOS).

Mild form of Hunter's syndrome: clinical delineation based on 31 cases.

Mechanism of glycosaminoglycan-mediated bone and joint disease: implications for the mucopolysaccharidoses and other connective tissue diseases.

New therapeutic options for lysosomal storage disorders: enzyme replacement, small molecules and gene therapy.

Mucopolysaccharidosis I: management and treatment guidelines.

P2888

s12519-014-0517-6

P304

226-231

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12519-014-0517-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Anna Tylki-Szymańska

Agnieszka Różdżyńska-Świątkowska

P577

2014-11-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

268790046

http://www.w3.org/2001/XMLSchema#string

P698

25410665

http://www.w3.org/2001/XMLSchema#string

Growth patterns in children with mucopolysaccharidosis I and II.

about

P2860

P2860

Growth patterns in children with mucopolysaccharidosis I and II.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P698